{
    "type": "ETP",
    "ucits": false,
    "replication_method": "physical",
    "leverage": true,
    "derivatives": false,
    "swaps": false,
    "inverse": true,
    "complex_factors": [
        "Leverage",
        "Inverse Exposure",
        "Daily Compounding",
        "High Risk Level"
    ],
    "classification": "complex",
    "supporting_data": "The product is a Collateralised Exchange Traded Security (ETP) designed to provide -5x the daily performance of the Nasdaq-100 Index, indicating significant leverage and inverse exposure. The replication method is physical, with underlying assets held in a margin account including securities loans and cash balances, and no mention of synthetic replication or swap agreements. There is no use of derivatives as an inherent part of the strategy, but the product uses daily leverage and inverse exposure, which are complexity triggers under MiFID II. The risk indicator is at the highest level 7/7, reflecting very high risk and complexity. The product is not UCITS compliant. The KIID explicitly states the product is 'not simple and may be difficult to understand' and is intended for sophisticated investors able to monitor daily due to compounding effects and leverage. The PRIIPs KID and factsheet confirm physical replication and no swap usage, but emphasize the leverage and inverse nature, daily rebalancing, and compounding effects that can cause returns to deviate significantly from the underlying index over periods longer than one day. These factors drive the classification as complex under MiFID II despite the absence of derivatives or swaps as part of the replication method."
}